BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26687891)

  • 21. Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study.
    Last A; Burr S; Alexander N; Harding-Esch E; Roberts CH; Nabicassa M; Cassama ETDS; Mabey D; Holland M; Bailey R
    Pathog Dis; 2017 Jul; 75(5):. PubMed ID: 28472466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies.
    Burton MJ; Rajak SN; Hu VH; Ramadhani A; Habtamu E; Massae P; Tadesse Z; Callahan K; Emerson PM; Khaw PT; Jeffries D; Mabey DC; Bailey RL; Weiss HA; Holland MJ
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003763. PubMed ID: 25970613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Chlamydiaceae and Chlamydia-like organisms on the ocular surface of children and adults from a trachoma-endemic region.
    Ghasemian E; Inic-Kanada A; Collingro A; Tagini F; Stein E; Alchalabi H; Schuerer N; Keše D; Babiker BE; Borel N; Greub G; Barisani-Asenbauer T
    Sci Rep; 2018 May; 8(1):7432. PubMed ID: 29743637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis.
    Pickering H; Burr SE; Derrick T; Makalo P; Joof H; Hayward RD; Holland MJ
    Parasit Vectors; 2017 Mar; 10(1):143. PubMed ID: 28288672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger.
    Abdou A; Nassirou B; Kadri B; Moussa F; Munoz BE; Opong E; West SK
    Br J Ophthalmol; 2007 Jan; 91(1):13-7. PubMed ID: 16899525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trachoma in South Africa.
    Ballard RC; Fehler HG; Fotheringham P; Sutter EE; Treharne JD
    Soc Sci Med; 1983; 17(22):1755-65. PubMed ID: 6648595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.
    Michel CE; Solomon AW; Magbanua JP; Massae PA; Huang L; Mosha J; West SK; Nadala EC; Bailey R; Wisniewski C; Mabey DC; Lee HH
    Lancet; 2006 May; 367(9522):1585-90. PubMed ID: 16698411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention.
    Zhang H; Kandel RP; Sharma B; Dean D
    Arch Ophthalmol; 2004 Apr; 122(4):511-6. PubMed ID: 15078668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.
    Migchelsen SJ; Martin DL; Southisombath K; Turyaguma P; Heggen A; Rubangakene PP; Joof H; Makalo P; Cooley G; Gwyn S; Solomon AW; Holland MJ; Courtright P; Willis R; Alexander ND; Mabey DC; Roberts CH
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005230. PubMed ID: 28099433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
    Senyonjo L; Addy J; Martin DL; Agyemang D; Yeboah-Manu D; Gwyn S; Marfo B; Asante-Poku A; Aboe A; Mensah E; Solomon AW; Bailey RL
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009744. PubMed ID: 34543293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for control of trachoma: observational study with quantitative PCR.
    Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
    Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of serology for elimination surveillance of trachoma.
    Pinsent A; Solomon AW; Bailey RL; Bid R; Cama A; Dean D; Goodhew B; Gwyn SE; Jack KR; Kandel RP; Kama M; Massae P; Macleod C; Mabey DCW; Migchelsen S; Müller A; Sandi F; Sokana O; Taoaba R; Tekeraoi R; Martin DL; White MT
    Nat Commun; 2018 Dec; 9(1):5444. PubMed ID: 30575720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards a safe and effective chlamydial vaccine: lessons from the eye.
    Mabey DC; Hu V; Bailey RL; Burton MJ; Holland MJ
    Vaccine; 2014 Mar; 32(14):1572-8. PubMed ID: 24606636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing the public health applications of Chlamydia trachomatis serology.
    Woodhall SC; Gorwitz RJ; Migchelsen SJ; Gottlieb SL; Horner PJ; Geisler WM; Winstanley C; Hufnagel K; Waterboer T; Martin DL; Huston WM; Gaydos CA; Deal C; Unemo M; Dunbar JK; Bernstein K
    Lancet Infect Dis; 2018 Dec; 18(12):e399-e407. PubMed ID: 29983342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a field test for antibodies against Chlamydia trachomatis during trachoma surveillance in Nepal.
    Sun MJ; Zambrano AI; Dize L; Munoz B; Gwyn S; Mishra S; Martin DL; Sharma S; West SK
    Diagn Microbiol Infect Dis; 2017 May; 88(1):3-6. PubMed ID: 28214223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of clinical trachoma and infection in Aboriginal communities.
    Michel CE; Roper KG; Divena MA; Lee HH; Taylor HR
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e986. PubMed ID: 21423648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.
    Hu VH; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2013; 7(2):e2020. PubMed ID: 23457650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.